Emily Farmer

996 total citations
25 papers, 706 citations indexed

About

Emily Farmer is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Emily Farmer has authored 25 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Emily Farmer's work include Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Emily Farmer is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (10 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Emily Farmer collaborates with scholars based in United States, South Korea and China. Emily Farmer's co-authors include Chien‐Fu Hung, T.‐C. Wu, Andrew Yang, John Lin, Deborah Marcellus, G. B. Vogelsang, V Altomonte, J. A. Grant, Brandon Lam and Tae Heung Kang and has published in prestigious journals such as Nature Communications, Blood and Virology.

In The Last Decade

Emily Farmer

25 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Farmer United States 14 353 253 188 161 111 25 706
W Strober United States 13 570 1.6× 125 0.5× 148 0.8× 152 0.9× 124 1.1× 22 875
Andrew Nesbitt United Kingdom 17 645 1.8× 184 0.7× 315 1.7× 126 0.8× 159 1.4× 53 1.3k
Xavier Lafarge France 14 602 1.7× 266 1.1× 71 0.4× 148 0.9× 238 2.1× 43 1.0k
S Inada Japan 9 282 0.8× 191 0.8× 315 1.7× 75 0.5× 75 0.7× 27 834
Sonja Lagström Finland 13 274 0.8× 110 0.4× 262 1.4× 162 1.0× 77 0.7× 22 791
Christian A. Schmidt Germany 17 813 2.3× 234 0.9× 214 1.1× 434 2.7× 195 1.8× 47 1.5k
Tanja Aarvak Norway 12 430 1.2× 75 0.3× 174 0.9× 347 2.2× 58 0.5× 17 880
Antonio Jiménez United States 17 148 0.4× 142 0.6× 327 1.7× 254 1.6× 428 3.9× 59 944
Irini Evnouchidou France 18 701 2.0× 373 1.5× 466 2.5× 480 3.0× 145 1.3× 32 1.3k
Mary Farrington United States 10 817 2.3× 79 0.3× 134 0.7× 70 0.4× 69 0.6× 14 1.2k

Countries citing papers authored by Emily Farmer

Since Specialization
Citations

This map shows the geographic impact of Emily Farmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Farmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Farmer more than expected).

Fields of papers citing papers by Emily Farmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Farmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Farmer. The network helps show where Emily Farmer may publish in the future.

Co-authorship network of co-authors of Emily Farmer

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Farmer. A scholar is included among the top collaborators of Emily Farmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Farmer. Emily Farmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Po‐Hao, et al.. (2020). NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells. Cancer Immunology Immunotherapy. 69(10). 2147–2155. 10 indexed citations
2.
Peng, Shiwen, Marietta Tan, Yen-Der Li, et al.. (2020). PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model. Cancer Immunology Immunotherapy. 70(4). 1049–1062. 24 indexed citations
3.
Chuang, Yu-Min, Liangmei He, Michael L. Pinn, et al.. (2020). Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis. Cellular and Molecular Immunology. 18(10). 2393–2401. 19 indexed citations
4.
Farmer, Emily, et al.. (2020). Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer. Recent results in cancer research. 217. 157–195. 22 indexed citations
5.
Kang, Tae Heung, Andrew Yang, Sung‐Eun Lee, et al.. (2020). Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. Nature Communications. 11(1). 1137–1137. 64 indexed citations
6.
Park, Sung Taek, Brandon Lam, Ya-Chea Tsai, et al.. (2020). Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis. Journal for ImmunoTherapy of Cancer. 8(1). e000480–e000480. 5 indexed citations
7.
Xing, Deyin, Yuehua Liu, Hyeon Jin Park, et al.. (2019). Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva. Human Pathology. 92. 67–80. 21 indexed citations
8.
Lee, Sung Yong, Jee Youn Oh, Tae Heung Kang, et al.. (2019). Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines. Journal of Biomedical Science. 26(1). 41–41. 11 indexed citations
9.
Kang, Tae Heung, Chih‐Ping Mao, Young Seob Kim, et al.. (2019). TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 260–260. 41 indexed citations
10.
Lee, Seung Min, et al.. (2018). Dissipative particle dynamics simulation of multicompartment micelle nanoreactor with channel for reactants. RSC Advances. 8(66). 37866–37871. 5 indexed citations
11.
Kim, Young Seob, In Duk Jung, Hee Dong Han, et al.. (2018). A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells. OncoImmunology. 7(10). e1472187–e1472187. 16 indexed citations
12.
Qiu, Jin, Shiwen Peng, Andrew Yang, et al.. (2018). Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growth. OncoImmunology. 7(8). e1463946–e1463946. 3 indexed citations
13.
14.
Farmer, Emily, et al.. (2018). Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases. Human Gene Therapy. 29(9). 971–996. 51 indexed citations
15.
Ma, Ying, Andrew Yang, Shiwen Peng, et al.. (2017). Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model. Vaccine. 35(31). 3850–3858. 11 indexed citations
16.
Yang, Andrew, Shiwen Peng, Emily Farmer, et al.. (2017). Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus. Cell & Bioscience. 7(1). 46–46. 8 indexed citations
17.
Yang, Andrew, Emily Farmer, John Lin, T.‐C. Wu, & Chien‐Fu Hung. (2016). The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Virus Research. 231. 148–165. 50 indexed citations
18.
Yang, Andrew, Emily Farmer, T.‐C. Wu, & Chien‐Fu Hung. (2016). Perspectives for therapeutic HPV vaccine development. Journal of Biomedical Science. 23(1). 75–75. 151 indexed citations
19.
Marcellus, Deborah, et al.. (1999). Etretinate Therapy for Refractory Sclerodermatous Chronic Graft-Versus-Host Disease. Blood. 93(1). 66–70. 58 indexed citations
20.
Friedman, Kenneth J., et al.. (1987). Superficial epithelioma with sebaceous differentiation. Journal of Cutaneous Pathology. 14(4). 193–197. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Strober Breakdown of academic impact, for papers by Andrew Nesbitt Breakdown of academic impact, for papers by Xavier Lafarge Breakdown of academic impact, for papers by S Inada Breakdown of academic impact, for papers by Sonja Lagström Breakdown of academic impact, for papers by Christian A. Schmidt Breakdown of academic impact, for papers by Tanja Aarvak Breakdown of academic impact, for papers by Antonio Jiménez Breakdown of academic impact, for papers by Irini Evnouchidou Breakdown of academic impact, for papers by Mary Farrington
Rankless by CCL
2026